Recombinant tetanus vaccine (E. coli)(Ncpc Genetech Biotech)

重组破伤风疫苗（大肠埃希菌）（华北制药金坦生物）

Report date: 2025/05/14 17:44:06

Base Information

Drug NameRecombinant tetanus vaccine (E. coli)(Ncpc Genetech Biotech)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTetanusClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNcpc Genetech Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNcpc Genetech Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsTetanusClostridium Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A